Dioglip-MP 1 Tablet ER
Marketer
Kardic Kare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Dioglip-MP 1 Tablet ER
Glycip-XR 1mg extended-release tablets combine medications to regulate blood glucose. Used alongside diet and exercise, this medication improves blood sugar management in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Always follow your physician's prescribed dosage and frequency for Glycip-XR. Take it with food to minimize stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double the dose to compensate. Overdosing can result in dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or missed meals raises the hypoglycemia risk; consistent blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating individuals must consult their doctor before use. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption, as it can heighten the risk of side effects.
Uses of Dioglip-MP 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Dioglip-MP 1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dioglip-MP 1 Extended-Release Tablet should be administered with a meal.
Common Side effects of Dioglip-MP 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Dioglip-MP 1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dioglip-MP 1 Extended-Release Tablet should be administered with a meal.
How Dioglip-MP 1 Tablet ER works:
Dioglip-MP 1 Extended-Release tablet combines the actions of glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse mechanisms to optimize blood glucose management when monotherapy or dual-agent regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dioglip-MP 1 Tablet ER and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Dioglip-MP 1 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dioglip-MP tablets may pose a risk to breastfeeding infants. Available evidence indicates potential transfer to breast milk, with possible adverse effects on the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Dioglip-MP 1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Dioglip-MP 1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Exercise caution when prescribing Dioglip-MP 1 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before administration. Dioglip-MP 1 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Dioglip-MP 1 Tablet ER :
Should you forget a Dioglip-MP 1 Tablet ER dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dioglip-MP 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently